Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Florian Heubach"'
Autor:
Amadeus T Heinz, Friso G.J. Calkoen, Alexander Derbich, Lea Miltner, Christian Seitz, Michaela Doering, Christiane Braun, Daniel Atar, Michael Schumm, Florian Heubach, Anne-Marie Arendt, Ansgar Schulz, Friedhelm R Schuster, Roland Meisel, Brigitte Strahm, Juergen Finke, Beatrice Heineking, Susanne Stetter, Gerda Silling, Daniel Stachel, Bernd Gruhn, Klaus-Michael Debatin, Juergen Foell, Johannes H Schulte, Wilhelm Woessmann, Christine Mauz-Körholz, Johanna Tischer, Tobias Feuchtinger, Rupert Handgretinger, Peter Lang
Publikováno v:
Haematologica, Vol 108, Iss 8 (2023)
Therapy-resistant viral reactivations contribute significantly to mortality after hematopoietic stem cell transplantation. Adoptive cellular therapy with virus-specific T cells (VST) has shown efficacy in various single-center trials. However, the sc
Externí odkaz:
https://doaj.org/article/6ada467cb16540358957b223184585b6
Autor:
Christian Martin Seitz, Tim Flaadt, Markus Mezger, Anne-Marie Lang, Sebastian Michaelis, Marie Katz, Desireé Syring, Alexander Joechner, Armin Rabsteyn, Nikolai Siebert, Sascha Troschke-Meurer, Maxi Zumpe, Holger N. Lode, Sile F. Yang, Daniel Atar, Anna-Sophia Mast, Sophia Scheuermann, Florian Heubach, Rupert Handgretinger, Peter Lang, Patrick Schlegel
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Haploidentical stem cell transplantation (haplo SCT) in Stage IV neuroblastoma relapsed patients has been proven efficacious, while immunotherapy utilizing the anti-GD2 antibody dinutuximab beta has become a standard treatment for neuroblastoma. The
Externí odkaz:
https://doaj.org/article/3db6c45432c649c5ab96cdd2344832c5
Autor:
Peter Lang, Michaela Döring, Patrick Hundsdörfer, Gundram Jung, Johannes H. Schulte, Patrick Schlegel, Barbara Lang, Martin Ebinger, Anne-Marie Lang, Rupert Handgretinger, Ursula Holzer, Hermann Kreyenberg, Thomas Eichholz, Angelika Eggert, Florian Heubach, Christian Seitz
Publikováno v:
Bone Marrow Transplantation. 54:689-693
Posttransplant relapsed B-cell precursor ALL can be cured by 2nd hematopoietic stem cell transplantation (HSCT) in 20% of patients. The major cause of death after second HSCT is leukemic relapse. One reliable predictor for survival after 2nd-HSCT are
Autor:
Marie Matela, Anne Schilling, Patrick Schlegel, Peter Lang, Tobias Feuchtinger, Michaela Döring, Max Wiedenmann, Alexander Jöchner, Anne-Marie Lang, Rupert Handgretinger, Annika Horrer, Armin Rabsteyn, Florian Heubach, Christian Seitz
Publikováno v:
Bone Marrow Transplantation. 54:727-732
Posttransplant treatment strategies are narrowed by the vulnerability of bone marrow. Building on immune cells with antitumor activity is a growing field in cancer therapy. Thus, transfer of expanded and preactivated immune cells is a promising inten
Autor:
Christian U. Blank, Michele Maio, Michael A. Postow, Benjamin Weide, Phillip Wong, Dirk Schadendorf, Anna Maria Di Giacomo, Florian Heubach, Jianda Yuan, Paolo A. Ascierto, Amir Khammari, Marnix H Geukes Foppen, Brigitte Dréno, Graham Pawelec, Claus Garbe, Emanuela Romano, Domenico Mallardo, Bastian Schilling, Jedd D. Wolchok, Kilian Wistuba-Hamprecht, Alexander Martens
Publikováno v:
European Journal of Cancer
European Journal of Cancer, 2017, 73, pp.61-70. ⟨10.1016/j.ejca.2016.12.011⟩
European Journal of Cancer, Elsevier, 2017, 73, pp.61-70. 〈10.1016/j.ejca.2016.12.011〉
European Journal of Cancer, Elsevier, 2017, 73, pp.61-70. ⟨10.1016/j.ejca.2016.12.011⟩
European Journal of Cancer, 2017, 73, pp.61-70. ⟨10.1016/j.ejca.2016.12.011⟩
European Journal of Cancer, Elsevier, 2017, 73, pp.61-70. 〈10.1016/j.ejca.2016.12.011〉
European Journal of Cancer, Elsevier, 2017, 73, pp.61-70. ⟨10.1016/j.ejca.2016.12.011⟩
International audience; The role of the assessment of peripheral T-cell phenotypes in predicting overall survival (OS) after ipilimumab treatment is unclear. Here, we analysed mononuclear cells in the blood before and at different time points during
Autor:
Patrick, Schlegel, Anne-Marie, Lang, Marie, Matela, Annika, Horrer, Anne, Schilling, Alexander, Jöchner, Max, Wiedenmann, Christian, Seitz, Michaela, Döring, Tobias, Feuchtinger, Florian, Heubach, Armin, Rabsteyn, Rupert, Handgretinger, Peter, Lang
Publikováno v:
Bone marrow transplantation. 54(Suppl 2)
Posttransplant treatment strategies are narrowed by the vulnerability of bone marrow. Building on immune cells with antitumor activity is a growing field in cancer therapy. Thus, transfer of expanded and preactivated immune cells is a promising inten
Autor:
Stephen D. Gillies, Peter Lang, Gundram Jung, Sabine Schleicher, Timo Manz, Rupert Handgretinger, Latifa Zekri, Hans-Jörg Bühring, Armin Rabsteyn, Florian Heubach, Patrick Schlegel
Publikováno v:
Cancer Immunology Research. 7:A131-A131
Introduction: Targeting disialoganglioside GD2 with monoclonal antibodies (mAbs) significantly improves survival in high-risk neuroblastoma (NB) patients after autologous or allogeneic SCT. However, GD2 expression is heterogeneous and the recently ap
Autor:
Ursula J.E. Seidel, Emmanuelle Moraes Ribeiro, Patrick Schlegel, Peter Lang, Florian Heubach, Christian Seitz, Rupert Handgretinger, Anne-Marie Lang, Armin Rabsteyn, Gundram Jung
Publikováno v:
Cancer Immunology Research. 7:A140-A140
Introduction: Whereas immunotherapy in high-risk/relapsed neuroblastoma with standard antibody formats targeting the tumor associated antigen GD2 is currently used after autologous/allogeneic stem cell transplantation (SCT), T-cells have rarely been
Publikováno v:
Cancer Immunology Research. 7:A080-A080
We investigated whether treatment with the T helper cell 1 (TH1) cytokines TNF-α and IFN-γ drives neuroblastoma (NB) cell lines into permanent growth arrest. Introduction: Most cancer immunotherapies focus on cytotoxic treatment strategies mediated